David Meeker
Tracked across 1 events · 6 articles · First seen Apr 03, 2026 · Last active May 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: David Meeker, Chairman, President and Chief Executive Officer of Rhythm Pharmaceuticals, commented on the significance of the International — European Commission's authorization for Setmelanotide (setmelanotide) in Europe.
May 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track David Meeker live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard